GLAXOSMITHKLINE US TRADING LIMITED - Profile & Financials

Accounts Submitted

Confirmation Statement Submitted 29 Sept 2025

Net assets £27.05M £6.57M 2024 year on year

Total assets £192.07M £45.17M 2024 year on year

Total Liabilities £165.02M £38.60M 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

C/O Bdo Llp, 5 Temple Square Temple Street Liverpool L2 5RH

Credit Report

Discover GLAXOSMITHKLINE US TRADING LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

N/A

Decreased by £1.47M (-100%)

Net Assets

£27.05M

Increased by £6.57M (+32%)

Total Liabilities

£165.02M

Increased by £38.60M (+31%)

Turnover

£815.43M

Increased by £239.92M (+42%)

Employees

N/A

Debt Ratio

86%

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

3 active 11 resigned

Show resigned officers

						Status
Aidan Lynch	Director	Irish	Ireland	62	10 Sept 2019	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-secretary	United Kingdom	Unknown	—	12 Sept 2018	Active
The Wellcome Foundation Limited	Corporate-director	United Kingdom	Unknown	—	12 Sept 2018	Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active

Notified 12 Sept 2018

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

GLAXOSMITHKLINE US TRADING LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
10 Nov 2025	Insolvency	Solvency Statement dated 05/11/25	View(1 page)
10 Nov 2025	Capital	Statement by Directors	View(1 page)
10 Nov 2025	Capital	Capital Statement Capital Company With Date Currency Figure	View(3 pages)
10 Nov 2025	Resolution	Resolutions	View(1 page)
29 Sept 2025	Confirmation Statement	Confirmation statement made on 2025-09-29 with no updates	View(3 pages)